Clinical Trials Browser

Klatskin Tumor

NCT07454486 2026-03-06

TRACE-BTC

Not yet recruiting

300 enrolled

Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Neoplasms, Cholangiocarcinoma, Klatskin Tumor, Neoplasm, Residual

NCT06109779 2026-03-04

Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)

Phase 3 Active not recruiting

757 enrolled

Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT06178588 2026-02-24

Sacituzumab Govitecan for the Treatment for Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma

Phase 2 Active not recruiting

15 enrolled

Gastrointestinal

Cholangiocarcinoma, Klatskin Tumor

NCT05430698 2026-02-09

PD-1 Antibody Plus GEMOX as Postoperative Adjuvant Therapy in Perihilar Cholangiocarcinoma

Phase 2 Recruiting

62 enrolled

Gastrointestinal

Klatskin Tumor

NCT06739252 2026-01-28

Perioperative Treatment of High-risk Resectable CCA With HAIC Plus A+T: Neobrave CCA

Phase 2 Terminated

1 enrolled

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma, Klatskin Tumor

NCT05993429 2026-01-26

Diagnostic Efficacy of EUS-FNA/B Versus ERCP With or Without POCS-TB in Patients With Suspected Hilar Cholangiocarcinoma

Completed

200 enrolled

Gastrointestinal

Cholangiocarcinoma, Klatskin Tumor

NCT07326189 2026-01-16

PHAE-PHCC

Phase NA Not yet recruiting

33 enrolled

Gastrointestinal

Klatskin Tumor

NCT07311798 2025-12-31

Impact of Vascular Resection on Survival and Postoperative Outcomes in Patients With Hilar Cholangiocarcinoma: A Retrospective Study

Not yet recruiting

300 enrolled

Gastrointestinal

Klatskin Tumor

NCT03104569 2025-12-26

Effect of 37℃ Non-ionic Contrast Agent During ERCP Procedure in Hilar Cholangiocarcinoma

Phase NA Not yet recruiting

100 enrolled

Gastrointestinal

Cholangitis, Klatskin Tumor

NCT06420349 2025-12-22

NXP800 for the Treatment of Patients With Advanced or Metastatic Cholangiocarcinoma

Phase 1 Terminated

7 enrolled

Gastrointestinal

Cholangiocarcinoma, Klatskin Tumor

NCT05024513 2025-12-18

Biliary Drainage Plus HAIC in Locally Advanced pCCA

Phase 2 Completed

127 enrolled

Gastrointestinal

Klatskin Tumor

NCT07176962 2025-09-16

A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening

Recruiting

1,800 enrolled

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Disease, Gallbladder Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT07161869 2025-09-09

POELH-III

Not yet recruiting

250 enrolled

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Biliary Tract Neoplasms, Common Bile Duct Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT07149558 2025-09-02

Volume-Restricted Resection for Perihilar Cholangiocarcinoma

Not yet recruiting

300 enrolled

Gastrointestinal

Klatskin Tumor

NCT06850753 2025-08-21

SURE-LT

Phase NA Recruiting

15 enrolled

Gastrointestinal

Klatskin Tumor

NCT05678218 2025-08-08

POELH-II

Completed

245 enrolled

Gastrointestinal

Adenocarcinoma, Common Bile Duct Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT04993131 2025-07-31

TESLA II

Phase NA Recruiting

15 enrolled

Gastrointestinal

Bile Duct Neoplasms, Klatskin Tumor

NCT03377179 2025-07-23

A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced Cholangiocarcinoma

Phase 2 Completed

65 enrolled

Gastrointestinal

Cholangiocarcinoma, Klatskin Tumor

NCT06493734 2025-07-15

STRONG II

Phase NA Recruiting

30 enrolled

Gastrointestinal

Klatskin Tumor

NCT04561453 2025-07-10

Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer

Terminated

14 enrolled

Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT07030140 2025-06-22

Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

Phase 2 Not yet recruiting

38 enrolled

Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT06986486 2025-05-23

pCOLA

Recruiting

8 enrolled

Gastrointestinal

Klatskin Tumor

NCT05239169 2025-05-01

Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer

Phase 2 Completed

40 enrolled

Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT06923475 2025-04-11

NEODISCO

Phase 2/3 Not yet recruiting

150 enrolled

Gastrointestinal

Cholangiocarcinoma, Klatskin Tumor

NCT05551299 2025-03-27

CARP

Phase 4 Recruiting

258 enrolled

Gastrointestinal

Bile Duct Neoplasms, Klatskin Tumor

Clinical Trials

LITALHICA

TRACE-BTC

Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)

Sacituzumab Govitecan for the Treatment for Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma

PD-1 Antibody Plus GEMOX as Postoperative Adjuvant Therapy in Perihilar Cholangiocarcinoma

Perioperative Treatment of High-risk Resectable CCA With HAIC Plus A+T: Neobrave CCA

Diagnostic Efficacy of EUS-FNA/B Versus ERCP With or Without POCS-TB in Patients With Suspected Hilar Cholangiocarcinoma

PHAE-PHCC

Impact of Vascular Resection on Survival and Postoperative Outcomes in Patients With Hilar Cholangiocarcinoma: A Retrospective Study

Effect of 37℃ Non-ionic Contrast Agent During ERCP Procedure in Hilar Cholangiocarcinoma

NXP800 for the Treatment of Patients With Advanced or Metastatic Cholangiocarcinoma

Biliary Drainage Plus HAIC in Locally Advanced pCCA

A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening

POELH-III

Volume-Restricted Resection for Perihilar Cholangiocarcinoma

SURE-LT

POELH-II

TESLA II

A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced Cholangiocarcinoma

STRONG II

Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer

Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

pCOLA

Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer

NEODISCO

CARP